The Latest Cardiac and Vascular News
DUBLIN – January 16, 2018 – Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio. The Riptide Aspiration System is designed to retrieve thrombus […]
Siemens Healthineers lays out strategy to bolster market leadership beyond 2025 London, 2018-Jan-16 Siemens Healthineers well prepared to take advantage of paradigm shift and structural growth opportunities in healthcare 2015 – 2017 performance illustrates strong financial profile Strategy aimed at accelerating profitable growth and delivering return Siemens Healthineers today laid out […]
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Jan 16, 2018 — Novoheart(“Novoheart” or the “Company”) (TSX VENTURE: NVH) today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a three-tiered drug screening system with enhanced capability, sensitivity and accuracy for detecting pharmacological effects […]
HOUSTON–(BUSINESS WIRE)–CorInnova Inc., an emerging medical device company developing breakthrough technology for the treatment of Heart Failure, announced today that it has won First Prize in the “RESI (Redefining Early Stage Investments) San Francisco 2018” investment competition for early-stage life science companies. “We are excited that early-stage investors instantly grasp the […]
SUNNYVALE, Calif., Jan. 11, 2018 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Beverly A. Huss to the company’s Board of Directors, effective January 7, 2018. Ms. Huss also currently serves on the boards of Qool Therapeutics, Inc., Surefire Medical, Inc., and Madorra. Her prior public company board experience includes Artes Medical, Wright […]
DANVERS, Mass., Jan. 12, 2018 (GLOBE NEWSWIRE) — Abiomed(NASDAQ:ABMD) announced that on Thursday, February 1, 2018, the Company will release financial results for the third quarter of fiscal 2018. The Company will host a conference call to discuss the results on Thursday, February 1, 2018, at 8:00 a.m. EST. Michael R. […]
Villepinte (France), January 8, 2018 (17:45 CET) – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical Therapeutics (“Accurate”), which specializes in the development of microcatheters used in […]
BANGALORE, January 5, 2018 /PRNewswire/ — iMedrix, a Silicon Valley and Bangalore-based mHealth start-up, announced the general availability of its product KardioScreen, a CE certified mobile/portable hospital grade digital ECG. KardioScreen is the first truly mobile, connected ECG solution that can be applied universally: field screening, point of care, ambulance, Cardiac ICU and […]
Handheld system rules out coronary arterial stenosis, saving valuable time in frontline triage and avoiding the need for expensive diagnostics. Acarix AB (publ) (“Acarix” or the “Company”) announced the initiation of a multi-center trial of its handheld CADScor®System for non-invasive, non-radiation acoustic detection of Coronary Artery Disease (“CAD”). The results […]
IRVINE, Calif., Jan. 11, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled the first patient in the WaveCrest® Investigational Device Exemption (IDE) Trial. The study will evaluate the safety and effectiveness of the WaveCrest® Left Atrial […]
